High-dose bisacodyl plus water lavage compared with oral sodium phosphate as bowel preparation for outpatient colonoscopy.

J Chin Med Assoc

Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, and School of Nursing, Fooyin University, Kaohsiung, Taiwan, R.O.C.

Published: August 2009

Background: The aim of this prospective study was to compare the efficacy and patient compliance of an oral high dose of bisacodyl plus water lavage and oral sodium phosphate in adults undergoing elective colonoscopy.

Methods: A total of 276 patients were randomized to receive an oral high-dose bisacodyl preparation (6 tablets of 5mg bisacodyl) plus water lavage (2 L of water) or an oral sodium phosphate (NaP) preparation (90 mL in divided doses). All endoscopic procedures were conducted in the afternoon. The endoscopist was blinded to the preparation the patient had received and graded the quality of colon cleansing as excellent, good, fair, poor, or failed. Patients' demographic data, indications for the procedure, and colonoscopic findings were recorded and compared.

Results: Significantly improved (p < 0.001) bowel preparation after NaP compared with bisacodyl plus water lavage was reported. The completion rate of colonoscopy was significantly lower (p < 0.001) in the bisacodyl group (70.6%) than in the NaP group (92.9%). The detection of polyps was significantly increased (p = 0.017) in the NaP group (43.1%) compared with the bisacodyl group (27.1%). A procedural indication of constipation was an independent predictor of failed preparation in the bisacodyl group (odds ratio, 4.8; 95% confidence interval, 1.9-12.0; p < 0.001).

Conclusion: The quality of bowel preparation with oral NaP was better than that with bisacodyl plus water lavage.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1726-4901(09)70396-XDOI Listing

Publication Analysis

Top Keywords

bisacodyl water
20
water lavage
20
oral sodium
12
sodium phosphate
12
bowel preparation
12
bisacodyl group
12
high-dose bisacodyl
8
bisacodyl
8
compared bisacodyl
8
nap group
8

Similar Publications

Bisacodyl is a widely used laxative that stimulates both motility and secretion. Our aim was to exploit the unique capabilities of MRI to define bisacodyl's mode of action. Two placebo-controlled cross-over trials were performed, one using a single dose of Bisacodyl 5 mg while the second dosed daily for 3 consecutive days.

View Article and Find Full Text PDF

Evaluations of the in vivo Laxative Effects of Aqueous Leaf and Stem Extracts of in Mice.

J Exp Pharmacol

March 2024

Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Background: People frequently complain of long-term constipation. The cost associated with using modern medications to treat constipation is significant, and the probability of encountering side effects is notably high. These limitations restrict their effectiveness in therapy, remain unresolved, and underscore the need for research on alternative therapeutic approaches.

View Article and Find Full Text PDF
Article Synopsis
  • This study developed an amorphous solid dispersion of bisacodyl, a poorly soluble drug, using hot-melt extrusion to improve its effectiveness.
  • Various analytical methods were employed to confirm the miscibility and interaction between bisacodyl and different polymers, with hydroxypropyl methylcellulose (HPMC) emerging as the best option due to its favorable properties.
  • The resulting HPMC-bisacodyl formulations showed significantly better therapeutic effects in rabbits with constipation compared to the un-solubilized version, demonstrating the successful application of pre-formulation strategies in enhancing drug solubility and efficacy.
View Article and Find Full Text PDF

In this study, the laxative effect of BC01 (BC01) in mice was investigated using a functional constipation mouse model. Six-week-old male specific pathogen-free (SPF) Kunming mice were randomly divided into five groups: normal control group (saline), model group (loperamide hydrochloride), drug control group (bisacodyl), BC01 low-dose group (4.0 × 10 CFU/mL) and BC01 high-dose group (4.

View Article and Find Full Text PDF

Effect of SNZ 1969 on the Improvement of Bowel Movement in Loperamide-Treated SD Rats.

Nutrients

September 2022

Department of Food Science and Nutrition, College of Science and Technology, Dankook University, Cheonan 31116, Korea.

SNZ 1969 ( SNZ 1969) is a spore-forming bacterium reported to be effective in attenuating constipation. However, there is no study on whether SNZ 1969 could improve constipation through mucin secretion and changes in intestinal hormones. To address this knowledge gap, rats were orally administrated with various treatments for four weeks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!